CLINICAL_TRIALS ClinicalTrials.gov record update

A Quality of Life Study of PEGASYS® (Peginterferon-Alfa2a) in Combination With COPEGUS® (Ribavirin) in Patients With Chronic Hepatitis C and Persistently Normal ALT Levels

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02726022
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:08.605824+00:00
Published At: 2016-08-15T00:00:00+00:00
Record Updated At: 2016-08-15
Results Posted At: 2016-08-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C, Chronic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-08-15"
protocolSection.identificationModule.nctId: "NCT02726022"
protocolSection.identificationModule.officialTitle: "A Quality of Life Study of PEGASYS\u00ae (Peginterferon-Alfa2a) in Combination With COPEGUS\u00ae (Ribavirin) in Patients With Chronic Hepatitis C and Persistently Normal ALT Levels"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-08-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.